Workflow
*ST双成: 海南双成药业股份有限公司第五届董事会第二十一次会议决议公告

Core Viewpoint - The company has approved a series of resolutions regarding the 2025 Restricted Stock and Stock Option Incentive Plan, aimed at enhancing corporate governance and motivating key employees for sustainable development [1][2][3]. Group 1: Board Meeting Details - The fifth session of the board's 21st meeting was held on August 30, 2025, with six directors participating and the meeting chaired by Chairman Wang Chengdong [1]. - The meeting complied with relevant laws, regulations, and the company's articles of association [1]. Group 2: Incentive Plan Resolutions - The board approved the draft of the 2025 Restricted Stock and Stock Option Incentive Plan to improve governance and establish a robust incentive mechanism [1][2]. - The plan aims to enhance the sense of responsibility and mission among the management team and core employees for the company's sustainable development [1]. Group 3: Voting Results - The voting results for the incentive plan draft showed 5 votes in favor, 1 abstention, and no opposition [2][5]. - Li Jianming, an associated director, abstained from voting on the proposal [2][5]. Group 4: Authorization for Implementation - The board proposed to authorize itself to handle matters related to the 2025 incentive plan, including determining grant dates and adjusting stock options in case of capital changes [3][4]. - The authorization includes managing the qualifications of participants and handling necessary documentation for granting stock options [4][5]. Group 5: Upcoming Shareholder Meeting - The board has proposed to convene the second extraordinary general meeting of shareholders in 2025 to discuss the incentive plan [5].